Literature DB >> 20529412

Abnormal cortisol awakening response predicts worse cognitive function in patients with first-episode psychosis.

M Aas1, P Dazzan, V Mondelli, T Toulopoulou, A Reichenberg, M Di Forti, H L Fisher, R Handley, N Hepgul, T Marques, A Miorelli, H Taylor, M Russo, B Wiffen, A Papadopoulos, K J Aitchison, C Morgan, R M Murray, C M Pariante.   

Abstract

BACKGROUND: Cognitive impairment, particularly in memory and executive function, is a core feature of psychosis. Moreover, psychosis is characterized by a more prominent history of stress exposure, and by dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis. In turn, stress exposure and abnormal levels of the main HPA axis hormone cortisol are associated with cognitive impairments in a variety of clinical and experimental samples; however, this association has never been examined in first-episode psychosis (FEP).
METHOD: In this study, 30 FEP patients and 26 controls completed assessment of the HPA axis (cortisol awakening response and cortisol levels during the day), perceived stress, recent life events, history of childhood trauma, and cognitive function. The neuropsychological battery comprised general cognitive function, verbal and non-verbal memory, executive function, perception, visuospatial abilities, processing speed, and general knowledge.
RESULTS: Patients performed significantly worse on all cognitive domains compared to controls. In patients only, a more blunted cortisol awakening response (that is, more abnormal) was associated with a more severe deficit in verbal memory and processing speed. In controls only, higher levels of perceived stress and more recent life events were associated with a worse performance in executive function and perception and visuospatial abilities.
CONCLUSIONS: These data support a role for the HPA axis, as measured by cortisol awakening response, in modulating cognitive function in patients with psychosis; however, this association does not seem to be related to the increased exposure to psychosocial stressors described in these patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20529412      PMCID: PMC3513413          DOI: 10.1017/S0033291710001170

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  67 in total

1.  The childhood experience of care and abuse questionnaire (CECA.Q): validation in a community series.

Authors:  A Bifulco; O Bernazzani; P M Moran; C Jacobs
Journal:  Br J Clin Psychol       Date:  2005-11

2.  Neurological abnormalities and cognitive ability in first-episode psychosis.

Authors:  Paola Dazzan; Tuhina Lloyd; Kevin D Morgan; Jolanta Zanelli; Craig Morgan; Ken Orr; Gerard Hutchinson; Paul Fearon; Matthew Allin; Larry Rifkin; Philip K McGuire; Gillian A Doody; John Holloway; Julian Leff; Glynn Harrison; Peter B Jones; Robin M Murray
Journal:  Br J Psychiatry       Date:  2008-09       Impact factor: 9.319

3.  Impaired declarative memory consolidation during sleep in patients with primary insomnia: Influence of sleep architecture and nocturnal cortisol release.

Authors:  Jutta Backhaus; Klaus Junghanns; Jan Born; Kornelia Hohaus; Frauke Faasch; Fritz Hohagen
Journal:  Biol Psychiatry       Date:  2006-07-28       Impact factor: 13.382

4.  A global measure of perceived stress.

Authors:  S Cohen; T Kamarck; R Mermelstein
Journal:  J Health Soc Behav       Date:  1983-12

5.  Neuroendocrine aspects of PTSD.

Authors:  R Yehuda
Journal:  Handb Exp Pharmacol       Date:  2005

Review 6.  HPA axis and memory.

Authors:  O T Wolf
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2003-06       Impact factor: 4.690

7.  Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatment.

Authors:  Valeria Mondelli; Paola Dazzan; Nilay Hepgul; Marta Di Forti; Monica Aas; Alessandro D'Albenzio; Marco Di Nicola; Helen Fisher; Rowena Handley; Tiago Reis Marques; Craig Morgan; Serena Navari; Heather Taylor; Andrew Papadopoulos; Katherine J Aitchison; Robin M Murray; Carmine M Pariante
Journal:  Schizophr Res       Date:  2009-09-13       Impact factor: 4.939

8.  Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia.

Authors:  P A Ringen; A Vaskinn; K Sundet; J A Engh; H Jónsdóttir; C Simonsen; S Friis; S Opjordsmoen; I Melle; O A Andreassen
Journal:  Psychol Med       Date:  2009-11-06       Impact factor: 7.723

Review 9.  The effects of stress and stress hormones on human cognition: Implications for the field of brain and cognition.

Authors:  S J Lupien; F Maheu; M Tu; A Fiocco; T E Schramek
Journal:  Brain Cogn       Date:  2007-04-26       Impact factor: 2.310

Review 10.  The HPA axis in major depression: classical theories and new developments.

Authors:  Carmine M Pariante; Stafford L Lightman
Journal:  Trends Neurosci       Date:  2008-07-31       Impact factor: 13.837

View more
  30 in total

1.  Nonhuman primate models of hippocampal development and dysfunction.

Authors:  Jocelyne Bachevalier
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

2.  Biomarkers and clinical staging in psychiatry.

Authors:  Patrick McGorry; Matcheri Keshavan; Sherilyn Goldstone; Paul Amminger; Kelly Allott; Michael Berk; Suzie Lavoie; Christos Pantelis; Alison Yung; Stephen Wood; Ian Hickie
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

3.  From stress to psychosis: whom, how, when and why?

Authors:  V Mondelli
Journal:  Epidemiol Psychiatr Sci       Date:  2014-06-06       Impact factor: 6.892

4.  Increased anxiety-like behaviors, but blunted cortisol stress response after neonatal hippocampal lesions in monkeys.

Authors:  Jessica Raper; Mark Wilson; Mar Sanchez; Christa Payne; Jocelyne Bachevalier
Journal:  Psychoneuroendocrinology       Date:  2016-11-18       Impact factor: 4.905

5.  Do child abuse and maltreatment increase risk of schizophrenia?

Authors:  Lucia Sideli; Alice Mule; Daniele La Barbera; Robin M Murray
Journal:  Psychiatry Investig       Date:  2012-04-30       Impact factor: 2.505

Review 6.  Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers - pre-clinical and clinical investigations.

Authors:  Joana Prata; Susana G Santos; Maria Inês Almeida; Rui Coelho; Mário A Barbosa
Journal:  J Neuroinflammation       Date:  2017-09-04       Impact factor: 8.322

7.  The cortisol awakening response and anterior cingulate cortex function in maltreated depressed versus non-maltreated depressed youth.

Authors:  Karina Quevedo; Jennifer Doty; Leslie Roos; Justin J Anker
Journal:  Psychoneuroendocrinology       Date:  2017-09-05       Impact factor: 4.905

8.  The emerging role of the FKBP5 gene polymorphisms in vulnerability-stress model of schizophrenia: further evidence from a Serbian population.

Authors:  Marina Mihaljevic; Katarina Zeljic; Ivan Soldatovic; Sanja Andric; Tijana Mirjanic; Alexander Richards; Kiran Mantripragada; Tatjana Pekmezovic; Ivana Novakovic; Nadja P Maric
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-08-23       Impact factor: 5.270

9.  Serotonin transporter gene polymorphism, childhood trauma, and cognition in patients with psychotic disorders.

Authors:  Monica Aas; Srdjan Djurovic; Lavinia Athanasiu; Nils Eiel Steen; Ingrid Agartz; Steinar Lorentzen; Kjetil Sundet; Ole A Andreassen; Ingrid Melle
Journal:  Schizophr Bull       Date:  2011-09-09       Impact factor: 9.306

10.  Childhood adversities and psychosis: evidence, challenges, implications.

Authors:  Craig Morgan; Charlotte Gayer-Anderson
Journal:  World Psychiatry       Date:  2016-06       Impact factor: 49.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.